Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of March 2026, with a specific report date of March 17, 2026. The document serves as a report of a foreign private issuer under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a corporate governance disclosure and does not contain financial performance data.
Material Changes
The primary material change disclosed is the resignation of Mr. Li Haixiang as a member of the Board of Directors, effective March 17, 2026. The Company explicitly stated that the resignation was not related to any disagreement with the Company regarding its operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on future performance, or discussion of risks and contingencies. The document is limited to the announcement of the board member's departure and standard incorporation by reference language for existing registration statements.
Investor Verification Checklist
- Verify the effective date of Mr. Li Haixiang's resignation (March 17, 2026).
- Confirm the stated reason for resignation (no disagreement with the Company).
- Check subsequent filings for the appointment of a replacement board member.
- Review the referenced Registration Statements (Form F-3 and Form S-8) for any impact on capital raising activities.